ArticleMolecular therapy oncolytics2022

DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas.

Xizhou Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.